Larvol Delta - Key-Program-Highlights-and-Updates

BBO-8520 - BridgeBio Oncology Therapeutics

BBO-11818 - BridgeBio Oncology Therapeutics

BBO-10203 - BridgeBio Oncology Therapeutics

https://www.globenewswire.com/news-release/2026/08/11/3343156/0/en/bbot-reports-second-quarter-2026-financial-results-and-update-on-corporate-progress.html

Aug 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next